Aripiprazole's receptor pharmacology and extrapyramidal side effects.
Poyurovsky
Michael
M
Weizman
Ronit
R
Weizman
Abraham
A
D017109:Akathisia, Drug-Induced / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000494:pharmacology; D000068180:Aripiprazole; D001480:Basal Ganglia Diseases / Q000139:chemically induced* / Q000503:physiopathology / Q000517:prevention & control; D018491:Dopamine Agonists / Q000494:pharmacology; D018492:Dopamine Antagonists / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D006801:Humans; D010879:Piperazines / Q000009:adverse effects* / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology; D049268:Positron-Emission Tomography; D011595:Psychomotor Agitation / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control; D015363:Quinolones / Q000009:adverse effects* / Q000494:pharmacology; D044282:Receptor, Serotonin, 5-HT1A / Q000187:drug effects / Q000235:genetics; D017448:Receptors, Dopamine D2 / Q000819:agonists / Q000187:drug effects* / Q000235:genetics; D012559:Schizophrenia / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000503:physiopathology; D058825:Serotonin 5-HT1 Receptor Agonists; D014508:Urea / Q000031:analogs & derivatives / Q000494:pharmacology
D014150:Antipsychotic Agents; D018491:Dopamine Agonists; D018492:Dopamine Antagonists; D010879:Piperazines; D010880:Piperidines; D015363:Quinolones; D017448:Receptors, Dopamine D2; D058825:Serotonin 5-HT1 Receptor Agonists; D044282:Receptor, Serotonin, 5-HT1A; D000068180:Aripiprazole; D014508:Urea; C510793:pimavanserin